BioXcel Therapeutics, Inc.
BTAIQ- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001720893
No open-market purchases or sales by BioXcel Therapeutics, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $8.69M in total; Oaktree Capital is the only superinvestor holding it.
13F holders, Q3 2021
Institutional positions in BioXcel Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 104
- −5 vs. Q2 2021
- Shares held
- 12.8M
- −238.4K (−1.8%) vs. Q2 2021
- Total value
- $388.3M
- +$9.62M (+2.5%) vs. Q2 2021
- New holders
- 12
- 50 more added
- Sold out
- 17
- 26 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BTAIQ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 47 | $8.69M |
| Q1 2026 | 40 | $7.28M |
| Q4 2025 | 41 | $5.66M |
| Q3 2025 | 35 | $6.05M |
| Q2 2025 | 35 | $1.09M |
| Q1 2025 | 31 | $769.7K |
| Q4 2024 | 49 | $3.22M |
| Q3 2024 | 50 | $1.89M |
| Q2 2024 | 74 | $12.5M |
| Q1 2024 | 74 | $26.1M |
| Q4 2023 | 73 | $27.6M |
| Q3 2023 | 86 | $25.8M |
| Q2 2023 | 88 | $117.8M |
| Q1 2023 | 97 | $325.0M |
| Q4 2022 | 84 | $288.9M |
| Q3 2022 | 85 | $140.3M |
| Q2 2022 | 94 | $167.4M |
| Q1 2022 | 96 | $273.9M |
| Q4 2021 | 93 | $283.1M |
| Q3 2021 | 104 | $388.3M |
| Q2 2021 | 109 | $378.6M |
| Q1 2021 | 118 | $475.2M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding BioXcel Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock Inc. | 1,216,737 | $36.9M | 0.00% | +84,335+7.4% | Added |
| State Street Corp | 1,328,599 | $40.3M | 0.00% | −130,516−8.9% | Reduced |
| Artemis Investment Management LLP | 1,380,260 | $41.9M | 0.33% | +186,970+15.7% | Added |
| FMR LLC | 3,785,384 | $114.9M | 0.01% | +670,571+21.5% | Added |
| Caas Capital Management LP | 0 | $0 | 0.00% | −232,285−100.0% | Sold out |
| Luminus Management LLC | 0 | $0 | 0.00% | −157,099−100.0% | Sold out |
| Blackstone Group Inc. | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −60,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −53,138−100.0% | Sold out |
| Kennedy Capital Management, Inc. | 0 | $0 | 0.00% | −40,532−100.0% | Sold out |
| GAM Holding AG | 0 | $0 | 0.00% | −15,600−100.0% | Sold out |
| HighPoint Advisor Group LLC | 0 | $0 | 0.00% | −12,185−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −8,750−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −7,650−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −7,186−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −647−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −315−100.0% | Sold out |
| Gemmer Asset Management LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| TCI Wealth Advisors, Inc. | 0 | $0 | 0.00% | −61−100.0% | Sold out |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −30−100.0% | Sold out |